Navigo, Mannin agree to develop affinity ligand against a novel drug for treatment of COVID-19
Navigo Proteins, a premier protein engineering company and developer of affinity ligands for custom chromatography solutions and Mannin, a subsidiary of Mannin Research Inc. (MRI), have agreed to develop a Precision X affinity ligand against the fusion protein of Angiopoietin-1 and Complement 4 Binding Protein (ANG1-C4BP) for use in GMP manufacturing. Mannin, and its parent […]
